Tags |
|
|
Links |
|
|
Digg It - Effortless Networking: Getting People To Follow Up With You
Do you have trouble following up with people you meet? Or getting people to follow up with yo
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
u?
You're not alone. This seems to be a common challenge.
This usually happens when
You're not alone. This seems to be a common challenge.
This usually happens when
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
the proper foundation hasn't been laid.
What do I mean by this?
Well, when you me
What do I mean by this?
Well, when you me
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
et someone for the first time, how do you know this is a person you want to follow up with?
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
In other words, what makes you want to follow up with this person? What kind of conversation
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
would you have, if you were able to follow up?
And if you're clear about why you
And if you're clear about why you
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
rong> want to have a follow up conversation with them later, how clear are theyIf yes, arrange then and there when and how you will reconnect with each other. If there
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
ng>?
Do they know and understand why you're interested in talking with them further? And if
Do they know and understand why you're interested in talking with them further? And if
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
so, is there similar interest on their side?
If this kind of groundwork hasn't been laid dur
If this kind of groundwork hasn't been laid dur
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
ing your initial conversation, following up can be (and usually is) a challenge.
So
So
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
here's how you lay the foundation:
- When you meet someone and you realize th
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
at you want to have at least one more conversation with them, tell them this. Tell them why y
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
ou want to talk with them further, but don't go into too much detail -- just provide the "hea
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
dline".
Then check to see if they share your interest about talking further.
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
is no interest, you can decide whether to let it go, or try to peak their interest in some ot
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
her way.
Without interest from the other person during the initial conversation, fol
Without interest from the other person during the initial conversation, fol
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
low up is nearly impossible.
If you go through this sequence during yo
If you go through this sequence during yo
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
ur initial conversation, you'll have what you need to follow up.
And neither of you should b
And neither of you should b
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
e hesitant or reluctant to follow up, because you both already agreed to it!
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.diggit.org.ua/article/32011/diggit-Effortless-Networking-Getting-People-To-Follow-Up-With-You.html">Effortless Networking: Getting People To Follow Up With You</a>
BB link (for phorums):
[url=http://www.diggit.org.ua/article/32011/diggit-Effortless-Networking-Getting-People-To-Follow-Up-With-You.html]Effortless Networking: Getting People To Follow Up With You[/url]
Related Articles:
Are You Managing Top-Down or Bottom-Up Or Both?
The ERP Implementation And Solving Some Issues Down The Road
Bookmark it:
|